World Jan 26, 2022
Pfizer and BioNTech launch trial of omicron-targeted COVID-19 vaccine
The companies plan to test the immune response generated by the omicron-based vaccine both as a three-shot regimen in unvaccinated people and as a booster shot.
Pfizer and BioNTech launch trial of omicron-targeted COVID-19 vaccine
The companies plan to test the immune response generated by the omicron-based vaccine both as a three-shot regimen in unvaccinated people and as a booster shot.
Pfizer starts making vaccine that targets both omicron and the original COVID virus
While research continues, Pfizer will evaluate the new hybrid shot against one specific to omicron and determine which should move forward by March, the firm's CEO has said.
What’s worst about omicron so far is the uncertainty
How should the world respond to omicron? We just have to wait as there is information that we don’t yet have. And for many, the waiting itself is the problem.
Pfizer submits COVID-19 vaccine data to U.S. regulators for use in younger kids
A Pfizer spokesperson said the company expects to start and complete its application very soon.
BioNTech vaccines finally reach Taiwan after heated political wrangling
Taiwan has blamed China, which claims the island as its own territory, for nixing an original order from the German firm earlier this year.
Taiwan says China blocked deal with BioNTech for COVID-19 shots
While Taiwan has previously said it had been unable to sign a final contract with BioNTech, it had only implied that Chinese pressure was to blame.
Pfizer and Moderna vaccines highly effective after first shot in real-world use, study finds
The results validate earlier studies that had indicated the vaccines begin to work soon after a first dose, and confirm that they also prevent asymptomatic infections.
Hong Kong offers a masterclass in vaccine confusion
Hong Kong was always going to struggle to run a mass vaccination campaign.
Pfizer-BioNTech shot could help end pandemic, Israel study shows
It was the largest study yet to quantify the impact of the vaccine outside the rigorous confines of a randomized, blinded clinical trial aimed at measuring effectiveness for regulators.
Pfizer-BioNTech shot stops COVID-19 spread, Israeli study shows
The study provides the first real-world indication that the immunization will curb transmission of the coronavirus, but experts cautioned that more data is needed.
Japan prepares to dispense Pfizer vaccine from Wednesday after formal approval
Up to 20,000 front-line medical staffers at state-run hospitals are set to be the first to receive the vaccines, followed by 3.7 million other health care workers.
Spread of variants sparks push for all-in-one COVID-19 vaccines
Dangerous coronavirus variants are carpeting the globe, pushing scientists in the U.K. and elsewhere to target multiple versions of the pathogen in a single shot.